PCD PHARMA FRANCHISE BUSINESS IN INDIA

PCD Pharma Franchise Business in India

PCD Pharma Franchise Business in India

Blog Article


 

Glywalk-M 40/500 Tablets—Dual Power for Effective Diabetes Management


PCD Pharma Franchise Business in India

Diabetes is not just a condition; it’s a growing health concern affecting millions across India. As the demand for reliable diabetic medications increases, patients and healthcare professionals alike are turning to proven, affordable solutions. Glywalk-M 40/500 Tablets, marketed by Biophar Group (a division of Biophar Lifesciences Pvt. Ltd.), offer a powerful combination of Gliclazide 40 mg and Metformin 500 mg—ideal for managing Type 2 Diabetes effectively.



???? Product Summary


 



    • MRP: ₹1550





    • Packing: 10*15 Blister





    • Category: Diabetic





    • Marketed By: Biophar Group, Division of Biophar Lifesciences Pvt. Ltd.



 



 Why Glywalk-M 40/500?


Glywalk-M combines two powerful anti-diabetic agents. PCD Pharma Franchise Business in India. On one hand, Gliclazide stimulates insulin secretion from the pancreas. On the other hand, Metformin decreases glucose production in the liver while improving insulin sensitivity.

As a result, this combination helps maintain healthy blood glucose levels and offers better long-term control.

Moreover, Glywalk-M is safe for prolonged use under medical supervision, making it a trusted choice for patients and physicians.



Key Advantages of Glywalk-M 40/500 Tablets


 


    1. Dual Action Therapy


        • Gliclazide promotes insulin secretion.



       


        • Metformin reduces hepatic glucose production.
          Therefore, this blend controls both fasting and postprandial blood sugar levels.



      Highly Recommended by Doctors



Due to its clinical efficacy and low side effect profile, Glywalk-M is widely recommended by healthcare professionals across India.


    1. Long-Term Safety



With a track record of safe use, Glywalk-M helps minimize diabetes-related complications over time.

 


    1. Convenient Blister Packaging
      Each 10*15 blister pack offers hygienic, easy-to-carry storage and improved shelf stability.

    2. Affordable Pricing, Despite its high efficacy, the medicine is economically priced at ₹1550—ideal for both patients and pharmacies. PCD Pharma Franchise Business in India



 



Bulk Supply of Glywalk-M 40/500 Tablets


If you are a hospital, distributor, stockist, or pharmacist, Biophar Group offers bulk purchase options for Glywalk-M 40/500. This allows you to maintain inventory levels consistently while benefiting from special pricing.

Additionally, we guarantee on-time delivery and full compliance with regulatory standards.

As such, many professionals across the country rely on Biophar Group for their long-term supply of quality diabetic medicines.



Start Your Own PCD Pharma Franchise in India


The pharmaceutical sector in India is growing rapidly, especially in the chronic care category. In particular, the demand for anti-diabetic medicines is booming due to the increasing number of diabetic patients. Therefore, starting a PCD Pharma Franchise in this therapeutic segment can be a highly profitable business.



Why Choose Biophar Group for PCD Pharma Franchise?


 


    1. Monopoly-Based Business Model
      We offer exclusive franchise rights in your region so you can grow without market saturation.

    2. Premium Quality Products



All our products are manufactured in WHO-GMP certified units under strict quality controls.
Moreover, every batch undergoes thorough testing for purity and consistency.

 


    1. Low Investment, High Return
      Our franchise plans require minimal investment, yet deliver maximum profits and business expansion opportunities.

    2. Strong Marketing Support,We provide promotional inputs like visual aids, reminder cards, MR bags, samples, and product brochures.



In addition, our support team offers guidance at every step of your business journey.


    1. Reliable Logistics, Our streamlined supply chain ensures your orders reach you quickly and without damage.



Consequently, you’ll never run out of stock during peak demand.

 



The Growing Diabetes Burden in India


India is often called the diabetes capital of the world, with over 77 million adults living with the condition. According to projections, this number may exceed 130 million by 2045. Hence, the need for affordable and effective anti-diabetic medicines like Glywalk-M 40/500 is greater than ever.

Furthermore, doctors are increasingly prescribing combination therapies to improve patient outcomes. Thus, Glywalk-M becomes an ideal product to stock in your pharmacy or include in your franchise business.

Contact Us – For Bulk Purchase & Franchise Opportunities


Whether you are planning to buy Glywalk-M 40/500 in bulk or wish to start your own PCD Pharma Franchise, Biophar Group is your trusted partner.

Get in touch with us today:

 

Additionally, our support staff will guide you step-by-step in setting up your business or fulfilling your bulk order efficiently.



Why Bulk Buyers Prefer Biophar Group


 


    • Competitive pricing on all high-demand products

    • Full product availability, even in remote regions

    • Custom packaging and labeling options (on request)

    • Transparent communication and ethical business practices

    • Trusted by 500+ distributors and franchise partners across India



 

As a result, Biophar Group has emerged as one of the most reliable pharma companies for bulk procurement and franchise development.



Conclusion


In summary, Glywalk-M 40/500 Tablets offer a clinically tested, dual-action solution for Type 2 Diabetes management. Backed by Biophar Group’s dedication to quality, affordability, and customer service, this product is perfect for doctors, wholesalers, and PCD Pharma Franchise aspirants.

Whether you want to:

 

Biophar Group is here to help you grow.

Therefore, act today and become part of one of India’s most progressive pharmaceutical networks.

Report this page